Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Therapy for Patients With Primary Uveal Melanoma With Genetic Imbalance

NCT01100528 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.

NCT NCT01100528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01100528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Therapy for Patients With Primary Uveal Melanoma With Genetic Imbalance
Lead sponsor
Case Comprehensive Cancer Center
Phase
Phase 2
Overall status
Completed
Start date
November 11, 2009
Completion date
December 14, 2017
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ciliary body and choroid melanoma, medium/large size, ciliary body and choroid melanoma, small size, iris melanoma, recurrent intraocular melanoma